Atlas Trials

Cinclus Pharma Holding AB

9 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Cinclus Pharma Holding AB

RecordFirmDate
A Study Comparing the Effect and Safety of Linaprazan Glurate to Lansoprazole in Maintenance of Healing in Participants With Healed Erosive Esophagitis (EE) Due to Gastroesophageal Reflux Disease (GERD) (NCT07313774)Cinclus Pharma Holding AB2026-03-01
A Study to Investigate the Effect of Linaprazan Glurate on the Pharmacokinetics of Amoxicillin (NCT07308041)Cinclus Pharma Holding AB2025-11-11
A Study Comparing the Effect and Safety of Linaprazan Glurate to Lansoprazole in Participants With Erosive Esophagitis (EE) Due to Gastroesophageal Reflux Disease (GERD) (NCT07037875)Cinclus Pharma Holding AB2025-09-11
Investigate Linaprazan Glurate/Linaprazan in Healthy Subjects (NCT05742984)Cinclus Pharma Holding AB2023-01-26
Effect of Clarithromycin on PK of Linaprazan, Linaprazan on PK of Clarithromycin and Linaprazan on PK of Midazolam (NCT05633147)Cinclus Pharma Holding AB2022-11-27
Relative Bioavailability of Linaprazan for the Test Formulation vs. Reference Formulation (NCT05627518)Cinclus Pharma Holding AB2022-11-15
A Study to Investigate the Pharmacokinetics and ECG Effects of Linaprazan Glurate (NCT05469854)Cinclus Pharma Holding AB2022-07-13
A Study in Patients With Erosive Esophagitis to Investigate Safety, Tolerability, and Healing Rates After 4 Weeks Treatment of X842 or Lansoprazole and Symptom Pattern During Subsequent 4 Weeks Treatment With Lansoprazole (NCT05055128)Cinclus Pharma Holding AB2021-08-11

Track Cinclus Pharma Holding AB automatically

Every clearance here is in the API, with alerts when new ones post.